We report a microfluidic platform for rapid screening and selection of monoclonal antibodies (mAbs) secreted by single cells. The microfluidic platform integrates single-cell handling and compartmentalization, fluorescence detection of antibod- ies secreted by cells, and cell recovery for reverse transcription polymerase chain reaction (RT-PCR) of antibody genes. 5 antibody-secreting cells, a typical fusion will yield less than 100 viable hybrid- omas. Therefore, fusions from tens to hundreds of animals are required to fully sample the antibody diversity produced in an immune response, making the hybridoma approach both time-consuming and expensive. As every antibody-producing cell (ASC) in the vertebrate immune system can produce a unique antibody, ASCs are an ideal system for single-cell analysis. Recently, antibodies have been selected from single cells without clonal expansion.(3) ASCs are harvested from immunized animals and monoclonal antibodies are produced by single-cell reverse-transcription polymerase chain reaction (RT-PCR) of antibody genes, followed by cloning and expression of these genes. Subsequently, all antibody genes are cloned and expressed in order to select antigen-specific mAbs, thereby making these single-cell techniques similarly expensive and time-consuming to other approaches requiring clonal expansion. We hypothesized that, by compart- mentalizing single cells in micro-fabricated wells 10 3 times smaller in volume ( 1µL), we could screen and select antibodies produced by single cells for their affinity and selectivity to target antigens. As ASCs are known to produce antibodies at a very high rate (1000s of molecules per second), they secrete detectable concentra- tions (>1nM) of antibodies within hours of incubation in a sub-nanoliter chamber. In contrast, in conventional 96-well plates, primary ASCs need to be cultured for up to one week in order to obtain detectable antibody concentrations; however, these cells cannot be efficiently cultured in laboratory conditions for longer than 1 day. Previous studies have shown that antibod- ies secreted by single cells can be detected in microfabricated sub-nanoliter wells using fluorescence microscopy. (4-5) We have developed a novel microfluidic technology for rapid screening and selection of monoclonal antibodies from single anti- body-secreting cells without clonal expansion. The microfluidic platform integrates the handling and compartmentalization of single cells, fluorescence measurements of antigen binding kinetics of antibodies secreted by single cells, and recovery of se- lected cells for off-chip reverse transcription polymerase chain reaction (RT-PCR) of antibody genes. THEORY